BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu G, Zhang Z, Song Q, Guo Y, Bao P, Shui H. Circ_0006528 Contributes to Paclitaxel Resistance of Breast Cancer Cells by Regulating miR-1299/CDK8 Axis. Onco Targets Ther 2020;13:9497-511. [PMID: 33061434 DOI: 10.2147/OTT.S252886] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Cheng H, Kuang S, Tan L, Sun S. Circ_0001955 plays a carcinogenic role in breast cancer via positively regulating GLUT1 via decoying miR-1299. Thorac Cancer 2022. [PMID: 35174654 DOI: 10.1111/1759-7714.14310] [Reference Citation Analysis]
2 Sun M, Liu X, Zhao W, Zhang B, Deng P. Circ_0058063 contributes to cisplatin-resistance of bladder cancer cells by upregulating B2M through acting as RNA sponges for miR-335-5p. BMC Cancer 2022;22:313. [PMID: 35321689 DOI: 10.1186/s12885-022-09419-1] [Reference Citation Analysis]
3 Guo Z, Guo A, Zhou C. Breast Cancer Stem Cell-Derived ANXA6-Containing Exosomes Sustain Paclitaxel Resistance and Cancer Aggressiveness in Breast Cancer. Front Cell Dev Biol 2021;9:718721. [PMID: 34676207 DOI: 10.3389/fcell.2021.718721] [Reference Citation Analysis]
4 Xu J, Chen X, Sun Y, Shi Y, Teng F, Lv M, Liu C, Jia X. The Regulation Network and Clinical Significance of Circular RNAs in Breast Cancer. Front Oncol 2021;11:691317. [PMID: 34307155 DOI: 10.3389/fonc.2021.691317] [Reference Citation Analysis]
5 Wang H, Shan S, Wang H, Wang X. CircATXN7 contributes to the progression and doxorubicin resistance of breast cancer via modulating miR-149-5p/HOXA11 pathway. Anticancer Drugs 2022;33:e700-10. [PMID: 34845164 DOI: 10.1097/CAD.0000000000001243] [Reference Citation Analysis]
6 Kaiyuan D, Lijuan H, Xueyuan S, Yunhui Z. The role and underlying mechanism of miR-1299 in cancer. Future Sci OA 2021;7:FSO693. [PMID: 34046198 DOI: 10.2144/fsoa-2021-0014] [Reference Citation Analysis]
7 Ni J, Xi X, Xiao S, Xiao X. Silencing of circHIPK3 Sensitizes Paclitaxel-Resistant Breast Cancer Cells to Chemotherapy by Regulating HK2 Through Targeting miR-1286. Cancer Manag Res 2021;13:5573-85. [PMID: 34285578 DOI: 10.2147/CMAR.S307595] [Reference Citation Analysis]
8 Peng YY, Sun D, Xin Y. Hsa_circ_0005230 is up-regulated and promotes gastric cancer cell invasion and migration via regulating the miR-1299/RHOT1 axis. Bioengineered 2022;13:5046-63. [PMID: 35170374 DOI: 10.1080/21655979.2022.2036514] [Reference Citation Analysis]
9 Zhong C, Wu K, Wang S, Long Z, Yang T, Zhong W, Tan X, Wang Z, Li C, Lu J, Mao X. Autophagy-related circRNA evaluation reveals hsa_circ_0001747 as a potential favorable prognostic factor for biochemical recurrence in patients with prostate cancer. Cell Death Dis 2021;12:726. [PMID: 34294687 DOI: 10.1038/s41419-021-04015-w] [Reference Citation Analysis]
10 Mahabady MK, Mirzaei S, Saebfar H, Gholami MH, Zabolian A, Hushmandi K, Hashemi F, Tajik F, Hashemi M, Kumar AP, Aref AR, Zarrabi A, Khan H, Hamblin MR, Nuri Ertas Y, Samarghandian S. Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity. J Cell Physiol 2022;237:2309-44. [PMID: 35437787 DOI: 10.1002/jcp.30751] [Reference Citation Analysis]
11 Tian T, Han J, Huang J, Li S, Pang H. Hypoxia-Induced Intracellular and Extracellular Heat Shock Protein gp96 Increases Paclitaxel-Resistance and Facilitates Immune Evasion in Breast Cancer. Front Oncol 2021;11:784777. [PMID: 34988020 DOI: 10.3389/fonc.2021.784777] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]